<PAGE> 1
EXHIBIT 10.43
SECURITIES PURCHASE AGREEMENT
AGREEMENT dated as of the 8th day of November, 2000 by and between
ADVANCED VIRAL RESEARCH CORP., a Delaware corporation (the "Company"), with
offices at 200 Corporate Boulevard South, Yonkers, New York 10701 and each of
those persons, severally and not jointly, listed as a purchaser on the Schedule
of purchasers attached as EXHIBIT B hereto. Such persons are hereafter
collectively referred to as the "Purchasers" and each individually as a
"Purchaser".
ARTICLE I
AUTHORIZATION OF THE SECURITIES
The Company represents that it has taken all corporate action necessary
to authorize the issuance and sale of up to (a) 50,000,000 shares of Common
Stock of the Company, par value $.00001 per share ("Common Stock") and (b)
warrants to purchase up to an aggregate of 30,000,000 shares of Common Stock of
the Company (the "Warrants"). The Common Stock and the Warrants (collectively,
the "Securities") are to be sold to each Purchaser pursuant to this Agreement.
For purposes of this Agreement the term "Shares" shall mean the shares of Common
Stock purchased hereunder and the shares of Common Stock which may be issued
from time to time pursuant to the exercise of the Warrants.
ARTICLE II
SALE AND PURCHASE OF THE SECURITIES; CLOSING
2.1. SALE AND PURCHASE OF THE SECURITIES. Subject to the terms and
conditions hereof and in reliance on the representations and warranties
contained herein, or made pursuant hereto, the Company will issue and sell to
each Purchaser, severally and not jointly, as more particularly referred to
below, and each Purchaser will purchase from the Company, on any Closing Date
specified in Section 2.2, the Securities for the purchase price set forth next
to the name of such Purchaser on Exhibit B, at an aggregate purchase price for
all Purchasers of $5,000,000 (the "Aggregate Purchase Price"). Additional
Purchasers may be added to Exhibit B and/or the amount of Securities purchased
by any one or more Purchasers set forth on Exhibit B may be increased between
the date hereof and the Last Closing Date, as defined in Section 2.2, and in
such event the Aggregate Purchase Price shall be deemed to be the aggregate
purchase price paid by all Purchasers purchasing Securities as of the Last
Closing Date; provided that the Aggregate Purchase Price shall not exceed
$20,000,000.
2.2. CLOSING.
(a) The closing of the purchase and sale of the Securities
shall take place at one or more closings (each, a "Closing"). A closing shall be
deemed to occur when this
1
<PAGE> 2
Agreement has been executed by both the Company and the Purchasers and the
Company has received payment for and issued all of the Securities. The initial
Closing will take place at such time and place or later date as may be mutually
agreed upon by the Company and the Purchasers participating in the initial
Closing, and shall be for an aggregate purchase price of not less than
$5,000,000. The date of any subsequent Closing or Closings will be mutually
agreed upon by the Company and a majority in interest of the Purchasers
participating in each such subsequent Closing, provided that no Closing shall
occur later than December 31, 2000 (the "Last Closing Date"). The date of any
Closing is referred to as a "Closing Date." The date on which this occurs is
herein called the "Closing Date."
(b) On the Closing Date there will be delivered to each
Purchaser (i) the shares of Common stock indicated on Exhibit B registered in
its name and (ii) warrant certificates in the forms of Exhibits A-1 and A-2
registered in such name representing the right to purchase the number of shares
of Common Stock set forth therein. The foregoing Securities shall be delivered
by the Company, against delivery by each Purchaser to the Company of an
unendorsed certified or official bank check drawn upon or issued by a bank which
is a member of the New York Clearinghouse for banks (or wire transfer) for the
aggregate purchase price to be paid by such Purchaser payable to the order of
the Company.
ARTICLE III
PURCHASERS' REPRESENTATIONS AND WARRANTIES
Each Purchaser represents and warrants to and covenants with the
Company that:
3.1. QUALIFIED BUYER. Purchaser is an "accredited investor" within the
meaning of Rule 501 of Regulation D promulgated under the Securities Act of
1933, as amended (the "Securities Act"). Either alone or together with the
advice of a representative, Purchaser is sophisticated and experienced in
making, and is qualified to make, decisions with respect to investments in
securities presenting an investment decision like that involved in the purchase
of the Securities, including investments in securities issued by the Company.
Purchaser has requested, received, reviewed and considered, either alone or with
a representative, all information Purchaser deems relevant in making an informed
decision to purchase the Securities, it being understood that such review will
not affect the validity of the representations of the Company in Article IV
hereof.
3.2. COMPLIANCE WITH LAWS. Purchaser will not, directly or indirectly,
offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to
buy, purchase or otherwise acquire or take a pledge of) any of the Securities
purchased hereunder except in compliance with the Securities Act, applicable
blue sky laws, and the rules and regulations promulgated thereunder.
3.3. QUALIFIED INVESTOR QUESTIONNAIRE. Purchaser has completed or
caused to be completed the Purchaser Questionnaire attached hereto as Appendix
I. The answers thereto are true and correct as of the date hereof and will be
true and correct as of the Closing (provided
2
<PAGE> 3
that Purchaser shall be entitled to update such information by providing notice
thereof to the Company prior to the Closing).
3.4. CAPACITY TO ENTER INTO AGREEMENT. Purchaser has full right, power,
authority and capacity to enter into this Agreement and to consummate the
transactions contemplated hereby. Upon the execution and delivery of this
Agreement by Purchaser, this Agreement shall constitute a valid and binding
obligation, enforceable in accordance with its terms, except (a) as
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors' and contracting
parties' rights generally, and (b) as limited by equitable principles generally.
3.5. OWNERSHIP IN THE COMPANY. Upon completion of the transaction or
upon exercise of any Warrant, Purchaser will not directly or beneficially own
more than 4.9% of the Common Stock of the Company.
3.6. INDEPENDENT INVESTIGATION. In electing to purchase the Securities
hereunder, Purchaser has relied solely upon the representations and warranties
of the Company set forth in this Agreement and on independent investigation made
by Purchaser and his representatives, if any, and Purchaser has not been given
any oral or written representations or assurance from the Company or any
representative of the Company other than as set forth in this Agreement or in a
document executed by a duly authorized representative of the Company making
reference to this Agreement.
3.7. NO GOVERNMENT RECOMMENDATION OR APPROVAL. Purchaser understands
that no United States federal or state agency, or similar agency of any other
country, has passed upon or made any recommendation or endorsement of the
Company, this transaction or the purchase of the Securities.
3.8. FURTHER LIMITATIONS ON DISPOSITION. Without in any way limiting
the representations set forth above, Purchaser agrees not to make any
disposition of all or any portion of the Warrants or the Shares issuable upon
the exercise of the Warrants unless and until (a) there is then in effect a
registration statement under the Securities Act covering such proposed
disposition and such disposition is made in accordance with such registration
statement, or (b) the disposition is made pursuant to an available exemption
from the registration requirements of the Securities Act and in the case of
clause (b) Purchaser shall have furnished the Company with such information as
the Company may reasonably require (including, if reasonably requested an
opinion of counsel, reasonably satisfactory to the Company), to confirm that
such disposition will not violate any of the securities laws of the United
States.
3.9. LEGAL REPRESENTATION. Purchaser has had the opportunity to be
represented in this transaction by counsel of his own choice and has been so
advised by counsel for the Company.
3.10. SEPARATE PURCHASERS. Each Purchaser is a separate investor; no
Purchaser is acting in concert with any other Purchaser or any other person in
connection with the purchase
3
<PAGE> 4
of Securities pursuant to this Agreement.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company represents and warrants as follows:
4.1. ORGANIZATION AND EXISTENCE, ETC. The Company is a corporation duly
organized and validly existing and in good standing under the laws of its
jurisdiction of incorporation, and has all requisite corporate power and
authority to carry on its business as now conducted and proposed to be
conducted; the Company has all requisite corporate power and authority to enter
into this Agreement, to issue the Securities as contemplated herein and the
Shares issuable upon exercise of the Warrants and to carry out and perform its
obligations under the terms and conditions of this Agreement. The Company does
not own or lease any property or engage in any activity in any jurisdiction
which might require qualification to do business as a foreign corporation in
such jurisdiction and where the failure to so qualify would have a material
adverse effect on the financial condition of the Company or subject the Company
to a material liability. To the extent the Company has not qualified to do
business in such jurisdictions, it has, as of the date hereof, prepared the
necessary applications or documents to be filed with the appropriate authorities
in such jurisdictions to obtain such qualifications.
4.2. AUTHORIZATION. All corporate action on the part of the Company and
the directors and stockholders of the Company necessary for the authorization,
execution, delivery and performance by the Company of this Agreement and the
transactions contemplated herein, and for the authorization, issuance and
delivery of the Securities and the Shares issuable upon exercise of the
Warrants, has been taken or will have been taken prior to the Closing. The
Shares, when issued and sold in accordance with the terms hereof, will be
validly issued, fully paid and non-assessable.
4.3. BINDING OBLIGATIONS; NO MATERIAL ADVERSE CONTRACTS, ETC. This
Agreement is a valid and binding obligation of the Company enforceable in
accordance with its terms. The execution, delivery and performance by the
Company of this Agreement and compliance herewith will not result in any
violation of and will not conflict with, or result in a breach of any of the
terms of, or constitute a default under, any provision of state or Federal law
to which the Company is subject, the Certificate of Incorporation, as amended,
or the By-laws, as amended, of the Company, or any mortgage, indenture,
agreement, instrument, judgment, decree, order, rule or regulation or other
restriction to which the Company is a party or by which it is bound, or, result
in the creation of any mortgage, pledge, lien, encumbrance or charge upon any of
the properties or assets of the Company pursuant to any such term. Except as set
forth herein, or as waived by such stockholder, no stockholder of the Company
has or will have any preemptive rights or rights of first refusal by reason of
the issuance of the Securities.
4.4. OFFERING. Subject in part to the truth and accuracy of the
representations made by each Purchaser herein and such Purchaser's compliance
with his covenants set forth
4
<PAGE> 5
in this Agreement, the offer, sale and issuance of the Warrants and the Shares
issuable upon exercise of the Warrants, in each case as contemplated by this
Agreement, are not subject to the registration requirements of the Securities
Act, and the Company, or anyone acting on its behalf, will not take any action
hereafter that would cause such registration requirements to be applicable.
4.5. SEC REPORTS. (a) The Company has filed with the Securities and
Exchange Commission (the "Commission") all reports ("SEC Reports") required to
be filed by it under the Securities Act of 1934, as amended (the "Exchange
Act"). All of the SEC Reports filed by the Company comply in all material
respects with the requirements of the Exchange Act. None of the SEC Reports
contains as of the respective dates thereof, any untrue statement of a material
fact or omits to state any material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances under which they were made. All financial statements contained in
the SEC Reports have been prepared in accordance with generally accepted
accounting principles consistently applied throughout the period indicated
("GAAP"). Each balance sheet presents fairly in accordance with GAAP the
financial position of the Company as of the date of such balance sheet, and each
statement of operations, of stockholders' equity and of cash flows presents
fairly in accordance with GAAP the results of operations, the stockholders'
equity and the cash flows of the Company for the periods then ended.
(b) No event has occurred since December 31, 1999 requiring the filing
of an SEC Report that has not heretofore been filed.
(c) The SEC Reports and this Agreement taken together as a whole will
not, as of the Closing Date, contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein, or necessary to
make the statements contained therein, in light of the circumstances under which
they were made, not misleading.
4.6. DISCLOSURE. The information heretofore provided and to be provided
pursuant to this Agreement, and each of the agreements, documents, certificates
and writings previously delivered to Purchaser or his representatives, do not
and will not contain any untrue statement of material fact and do not and will
not omit to state a material fact required to be stated herein or therein or
necessary in order to make the statements and writings contained herein and
therein not false or misleading in light of the circumstances under which they
were made. To the knowledge of the Company, there is no fact which materially
adversely affects the business, prospects or condition (financial or otherwise)
of the Company which has not been set forth herein.
ARTICLE V
CONDITIONS TO PURCHASERS CLOSING
Each Purchaser's obligation to purchase the Securities at the Closing
is subject to the fulfillment to such Purchaser's satisfaction on or prior to
the Closing Date of each of the following conditions, any of which may be waived
by such Purchaser:
5
<PAGE> 6
5.1. REPRESENTATIONS AND WARRANTIES CORRECT. The representations and
warranties in Article IV hereof shall be true and correct in all material
respects when made, and shall be true and correct in all material respects on
the Closing Date with the same force and effect as if they had been made on and
as of the Closing Date.
5.2. PERFORMANCE. All covenants, agreements and conditions contained in
this Agreement to be performed or complied with by the Company on or prior to
the Closing Date shall have been performed or complied with by the Company in
all material respects.
5.3. NO IMPEDIMENTS. Neither Purchaser nor the Company shall be subject
to any order, decree or injunction of a court or administrative agency of
competent jurisdiction which would impose any material limitation on Purchaser's
ability to exercise full rights of ownership of the Securities.
5.4. OTHER AGREEMENTS. The Company shall have issued to Purchaser all
of the Securities.
5.5. LEGAL INVESTMENT. At the time of the Closing, the purchase of the
Securities to be purchased hereunder shall be legally permitted by all laws and
regulations to which Purchaser and the Company are subject.
5.6. PROCEEDINGS AND OTHER DOCUMENTS. All corporate and other
proceedings in connection with the transactions contemplated by this Agreement
shall have been taken and Purchaser shall have received such other documents, in
form and substance reasonably satisfactory to Purchaser, as to such other
matters incident to the transaction contemplated hereby as Purchaser may
reasonably request.
ARTICLE VI
CONDITIONS TO CLOSING OF THE COMPANY
The Company's obligation to sell the Securities at the Closing is
subject to the fulfillment to its satisfaction on or prior to the Closing Date
of each of the following conditions:
6.1. REPRESENTATIONS. The representations made by each Purchaser in
Article III hereof shall be true and correct when made and shall be true and
correct on the Closing Date.
6.2. LEGAL INVESTMENT. At the time of the Closing, the offer, sale and
purchase of the Securities shall be legally permitted by all laws and
regulations to which the Purchasers and the Company are subject.
6.3. PAYMENT OF PURCHASE PRICE. The Company shall have received payment
in full of the Aggregate Purchase Price.
6
<PAGE> 7
ARTICLE VII
AFFIRMATIVE COVENANTS AND INDEMNITY
The Purchasers and the Company hereby covenant and agree as follows:
7.1. FURTHER ASSURANCES. From time to time the Company shall execute
and deliver to each Purchaser and each Purchaser shall execute and deliver to
the Company such other instruments, certificates, agreements and documents and
take such other action and do all other things as may be reasonably requested by
the other party in order to implement or effectuate the terms and provisions of
this Agreement and any of the Securities.
7.2. REGISTRATION RIGHTS.
(a) The Company shall use its best efforts to file on or
before the date which is 60 days after the Company is given written notice by
counsel for the Purchasers that no additional persons shall make purchases of
the Securities under this Agreement (the "Deadline"), a registration statement
(the "Registration Statement") with the Commission, on such form as the Company
deems to be appropriate, to register under the Securities Act for resale by the
holders thereof the Shares which may be acquired upon exercise of the Warrants.
The Company shall thereafter use its best efforts to cause the Registration
Statement to be declared effective by the Commission. If for any reason (other
than the failure of one or more Purchasers to provide the information requested
pursuant to Section 7.2(b) in which event the filing deadline shall be extended
by one day for each day beyond the 10th day after written request therefor
during which the information is not provided) the Registration Statement is not
filed on or before the Deadline, then, subject to the next sentence, the Company
shall pay to the Purchasers (PRO RATA based on the Shares being acquired by
each) liquidated damages in an amount equal to .025% of the Aggregate Purchase
Price per business day until the Registration Statement is filed, it being
agreed that this amount represents the parties' best estimate of the actual
damages to the purchasers. The maximum aggregate amount of liquidated damages
that the Company shall be required to pay to the Purchasers under this Section
7.2(b) shall be 2% of the Aggregate Purchase Price.
(b) Each Purchaser shall furnish to the Company such
information as the Company shall reasonably request in writing and as shall be
required in connection with the registration.
7.3. INDEMNIFICATION.
(a) The Company agrees to indemnify and hold each Purchaser
harmless from and against any losses, claims, damages or liabilities to which
such Purchaser may become subject (under the Securities Act or otherwise)
insofar as such losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) arise out of, or are based upon, any Untrue
Statement (as defined below) on or after the effective date of the Registration
7
<PAGE> 8
Statement, or arise out of any failure by the Company to fulfill any undertaking
included in the Registration Statement, and the Company will reimburse such
Purchaser any reasonable legal or other expenses reasonably incurred in
investigating, defending or preparing to defend any such action, proceeding or
claim; PROVIDED, HOWEVER, that the Company shall not be liable in any such case
to the extent that such loss, claim, damage or liability arises out of, or is
based upon, an Untrue Statement made in such Registration Statement in reliance
upon and in conformity with written information furnished to the Company by such
Purchaser or on such Purchaser's behalf, specifically for use in preparation of
the Registration Statement, or any statement or omission in any prospectus that
is corrected in any subsequent prospectus that was delivered prior to the
pertinent sale or sales by such Purchaser of his Shares.
(b) Each Purchaser agrees to indemnify and hold harmless the
Company and each person, if any, who controls the Company within the meeting of
Section 15 of the Securities Act, each officer of the Company who signs the
Registration Statement and each director of the Company from and against any
losses, claims, damages or liabilities to which the Company or any such officer,
director or controlling person may become subject (under the Securities Act or
otherwise), including, but not limited to, any legal or other expenses
reasonably incurred in investigating, defending or preparing to defend any such
action, proceeding or claim, insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of, or are
based upon, any failure to comply with such Purchaser's representation and
warranties hereunder, or any Untrue Statement contained in the Registration
Statement on or after the effective date thereof if such Untrue Statement was
made in reliance upon and in conformity with written information furnished by
such Purchaser or on such Purchaser's behalf specifically for use in preparation
of the Registration Statement; PROVIDED, HOWEVER, that in no event shall such
Purchaser's indemnity exceed the gross proceeds received by Purchaser from the
sale of Shares covered by such Registration Statement.
(c) Promptly after receipt by any indemnified person of a
notice of a claim or the beginning of any action in respect of which indemnity
is to be sought against an indemnifying person pursuant to this section, such
indemnified person shall notify the indemnifying person in writing of such claim
or of the commencement of such action, and, subject to the provisions
hereinafter stated, in case any such action shall be brought against an
indemnified person and such indemnifying person shall have been notified
thereof, such indemnifying person shall be entitled to participate therein, and,
to the extent it shall wish, to assume the defense thereof, with counsel
reasonably satisfactory to such indemnified person. After notice from the
indemnifying person to such indemnified person of its election to assume the
defense thereof, such indemnifying person shall not be liable to such
indemnified person for any legal expenses subsequently incurred by such
indemnified person in connection with the defense thereof; PROVIDED, HOWEVER,
that if there exists or shall exist a conflict of interest that would make it
inappropriate, in the opinion of counsel to the indemnified person, for the same
counsel to represent both the indemnified person and such indemnifying person or
any affiliate or associate thereof, the indemnified person shall be entitled to
retain its own counsel at the expense of such indemnifying person; PROVIDED
FURTHER, HOWEVER, that no indemnifying
8
<PAGE> 9
person shall be responsible for the fees and expenses of more than one separate
counsel for all indemnified parties.
(d) "Untrue Statement" means any untrue statement or alleged
untrue statement, or any omission or alleged omission to state in the
Registration Statement a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading.
ARTICLE VIII
COMPLIANCE WITH THE SECURITIES ACT
8.1. LEGENDS. The certificate(s)representing the Warrants delivered to
the Purchasers at Closing (and the Shares issued upon exercise of the Warrants)
shall be stamped or otherwise imprinted with a legend substantially similar the
following (in addition to any other legend required under applicable state
securities laws):
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933 (THE "ACT") AND MAY NOT BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER
THE ACT OR, IN THE OPINION OF COUNSEL OR BASED ON OTHER WRITTEN EVIDENCE IN THE
FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER,
SALE OR TRANSFER, PLEDGE, OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.
ARTICLE IX
MISCELLANEOUS
9.1. GOVERNING LAW. This Agreement and the rights of the parties
hereunder shall be governed in all respects by the laws of the State of New
York.
9.2. SURVIVAL. The representations, warranties, covenants and
agreements made herein shall survive the Closing, for a period of one year from
the date of Closing.
9.3. SUCCESSORS AND ASSIGNS. Except as otherwise expressly provided
herein, the provisions hereof shall inure to the benefit of, and be binding upon
and enforceable by and against, the successors, assigns, heirs, executors and
administrators of the parties hereto; PROVIDED, HOWEVER, that the Company may
not assign its rights hereunder.
9.4. ENTIRE AGREEMENT. This Agreement (including the Exhibits hereto)
and the other documents delivered pursuant hereto and simultaneously herewith
constitute the full and entire understanding and agreement between the parties
with regard to the subject matter hereof and thereof.
9
<PAGE> 10
9.5. AMENDMENT. This Agreement may not be amended, discharged or
terminated without the written consent of each Purchaser and that of the
Company.
9.6. NOTICES, ETC. All notices, demands or other communications given
hereunder shall be in writing and shall be sufficiently given if delivered
either personally or by a nationally recognized courier service marked for next
business day delivery or sent in a sealed envelope by first class mail, postage
prepaid and either registered or certified, addressed as follows:
if to the Company:
Advanced Viral Research Corp.
200 Corporate Boulevard South
Yonkers, New York 10701
Attention: Shalom Z. Hirschman, M.D.
President and Chief Executive Officer
(a) if to Purchaser, to the address set forth on Exhibit B to
this Agreement or to such other address with respect to any party hereto as such
party may from time to time notify (as provided above) the other parties hereto.
Any such notice, demand or communication shall be deemed to have been given (i)
on the date of delivery, if delivered personally, (ii) one business day after
delivery to a nationally recognized overnight courier service, if marked for
next day delivery or (iii) five business days after the date of mailing, if
mailed.
Copies of any notice, demand or communication given to the Company
shall be delivered to Wolf, Block, Schorr and Solis-Cohen LLP, 250 Park Avenue,
New York, New York, 10177, Attn.: Robert E. Fischer, Esq., or such other address
as may be directed.
9.7. DELAYS OR OMISSIONS. No delay or omission to exercise any right,
power or remedy accruing to any holder of any Securities upon any breach or
default of the Company under this Agreement shall impair any such right, power
or remedy of such holder nor shall it be construed to be a waiver of any such
breach or default, or an acquiescence, therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default theretofore or
thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any holder of any breach or default under this
Agreement, or any waiver on the part of any holder of any provisions or
conditions of this Agreement must be made in writing and shall be effective only
to the extent specifically set forth in such writing. Except as otherwise
provided herein, all remedies, either under this Agreement or by law or
otherwise afforded to any holder, shall be cumulative and not alternative.
9.8. SEVERABILITY. In case any provision of this Agreement shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.
10
<PAGE> 11
9.9. PLACEMENT FEE. Each Purchaser hereby represents and warrants to
the Company that he has not retained a finder or broker in connection with the
transactions contemplated by this Agreement. The Company agrees to indemnify and
to hold each Purchaser harmless of and from any liability for commission or
compensation in the nature of an agent's or broker's fee to any broker, person
or firm claiming to have been retained by Company to act as a finder or broker
in connection with this transaction and the costs and expenses of defending
against such liability or asserted liability. Each Purchaser agrees to indemnify
and to hold the Company harmless of and from any liability for commission or
compensation in the nature of an agent's or broker's fee to any broker, person
or firm claiming to have been retained by or on behalf of such Purchaser to act
as a finder or broker in connection with this transaction and the costs and
expenses of defending against such liability or asserted liability.
9.10. EXPENSES. Each of the parties shall bear its own expenses and
legal fees incurred on its behalf with respect to the negotiation, execution and
consummation of the transactions contemplated by this Agreement, except that on
the Closing Date the Company shall pay (i) the reasonable fees and disbursements
of Salans Hertzfeld Heilbronn Christy & Viener, counsel to the Purchasers, and
(ii) a fee to Lawrence Pomerantz equal to 5% of the Aggregate Purchase Price.
9.11. LITIGATION. The parties each hereby waive trial by jury in any
action or proceeding of any kind or nature in any court in which an action may
be commenced arising out of this Agreement or by reason of any other cause or
dispute whatsoever between them. The parties hereto agree that the State and
Federal Courts which sit in the State of New York and the County of New York
shall have exclusive jurisdiction to hear and determine any claims or disputes
between the Company and such holders, pertaining directly or indirectly to this
Agreement or to any matter arising therefrom. The parties each expressly submit
and consent in advance to such jurisdiction in any action or proceeding
commenced in such courts provided that such consent shall not be deemed to be a
waiver of personal service of the summons and complaint, or other process or
papers issued therein. The choice of forum set forth in this Section 9.11 shall
not be deemed to preclude the enforcement of any judgment obtained in such forum
or the taking of any action under this Agreement to enforce same in any
appropriate jurisdiction. The parties each waive any objection based upon forum
non conveniens and any objection to venue of any action instituted hereunder.
9.12. TITLES AND SUBTITLES. The titles of the articles, sections and
subsections of this Agreement are for convenience of reference only and are not
to be considered in construing this Agreement.
9.13. COUNTERPARTS. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.
11
<PAGE> 12
If a Purchaser is in agreement with the foregoing, such Purchaser
should sign where indicated below and thereupon this letter shall become a
binding agreement between such Purchaser and the Company.
Very truly yours,
ADVANCED VIRAL RESEARCH CORP.
By:
------------------------------------------
Name: Shalom Z. Hirschman, M.D.
Title: President and Chief Executive Officer
AGREED TO:
PURCHASER
Signature
Print Name
By:
-------------------------------------------------
Title:
----------------------------------------------
Address:
-------------------------------------------
12
<PAGE> 13
13
<PAGE> 14
EXHIBIT B
TO
SECURITIES PURCHASE AGREEMENT
DATED NOVEMBER 8, 2000
BETWEEN ADVANCED VIRAL RESEARCH CORP.
AND THE PURCHASERS THEREIN
<TABLE>
<CAPTION>
NAME AND ADDRESS NUMBER OF SHARES NUMBER OF
OF PURCHASER AMOUNT OF COMMON STOCK WARRANTS*
------------ ------ --------------- --------
<S> <C> <C> <C>
Paul Alberti $100,000 250,000 150,000
Elliot Bauer $120,000 300,000 180,000
Bridge Ventures, Inc. $100,000 250,000 150,000
Leonard Cohen $240,000 600,000 360,000
David Cohen $120,000 300,000 180,000
Todd A. Cohen $150,000 375,000 225,000
Gerold Director $80,000 200,000 120,000
Joseph Giamanco $80,000 200,000 120,000
Edward D. Gorkes $200,000 500,000 300,000
Bernard Gutherz $100,000 250,000 150,000
Linda Halpert $80,000 200,000 120,000
Barry L. Johnston $100,000 250,000 150,000
Benjamin Kirsch $240,000 600,000 360,000
Roy D. Mittman $50,000 125,000 75,000
Jonas Parnes $44,000 110,000 66,000
Kenneth I. Schatz $160,000 400,000 240,000
Frank Vigliarolo $178,000 445,000 267,000
Barry Weshnak $80,000 200,000 120,000
</TABLE>
-----------------
*50% of such Warrants have an exercise price of $.48 per share and 50% of such
warrants have an exercise price of $.56 per share.
14
